Product Clinical Trials


Evidence Based Efficacy

As a pioneer in human studies in cannabinoids, funded by the NIH, some of our products are a result of evidence-based efficacy. With significant results in appetite suppression, pain, sleep, anxiety and skin conditions, we hope you enjoy our remedies.

  • Double-blind clinical studies show that patients reported a drop in mild to moderate pain (Chong 2019)
  • Double-blind clinical studies show a 3-point drop in anxiety (MRS score)
  • Double-blind clinical studies show that 91% of the patients reported improvement in sleep and more dreaming
  • Double-blind clinical studies show statistical reduction in the body’s inflammation
  • Double-blind clinical studies show statistical reduction in blood sugar levels
  • Double-blind clinical studies show statistical reduction in blood pressure
  • Double-blind clinical studies show statistical reduction average 8-14 pounds in 90 days
  • Double-blind clinical studies show statistical reduction average up to 4” abdominal girth
  • Double-blind clinical studies show significant increase in the calories burned within 90 days
  • Double-blind clinical studies show significant increase in deep sleep
  • Double-blind clinical studies show significant increase in REM sleep
  • Double-blind clinical studies show significant decrease in awake minutes per night
  • Double-blind clinical studies show significant decrease in resting heart rate